Common Stock, Shares, Outstanding of LENZ Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
LENZ Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • LENZ Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 28,588,261, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

LENZ Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 28,588,261 +1,107,627 +4% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 28,500,122 +2,654,451 +10% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 27,535,663 +2,035,533 +8% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 27,518,439 +25,549,079 +1297% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 27,480,634 -30,491,276 -53% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 25,845,671 -32,143,602 -55% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 25,500,130 -32,694,688 -56% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 1,969,360 -56,252,400 -97% 31 Dec 2023 10-K 19 Mar 2025 2024 FY
Q3 2023 57,971,910 -177,407 -0.3% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 57,989,273 -221,919 -0.38% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 58,194,818 +183,995 +0.32% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 58,221,760 +210,937 +0.36% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 58,149,317 +70,315 +0.12% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 58,211,192 +2,232,190 +4% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 58,010,823 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 58,010,823 +47,731,721 +464% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 58,079,002 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 55,979,002 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q4 2020 10,279,102 31 Dec 2020 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.